The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
August 29th 2025
An international BMJ panel recommended broader use of SGLT-2 inhibitors and GLP-1 receptor agonists.
NCPA Backs Generic Drug Payment Legislation
January 12th 2015Bipartisan legislation recently introduced, and endorsed today by the National Community Pharmacists Association , would help prevent community pharmacists from being collateral damage as some generic drug prices spike dramatically but federal health plan reimbursements fail to keep pace.
Read More
Analysis of 12 Studies Links HIV Risk to Contraceptive Use
January 12th 2015Data published in The Lancet Infectious Diseases on Jan. 8 shows that some contraceptives for women may increase the risk of contracting HIV. This information comes from researchers from the University of California Berkeley, who analyzed 12 studies.
Read More
Pharmacy Blood Pressure Monitoring Kiosks Comparable to Ambulatory Assessment
January 11th 2015Results of a peer-reviewed clinical study support the use of pharmacy-based PharmaSmart kiosks in assessing hypertension, as the routine blood pressure testing on the kiosks was deemed comparable to daytime ambulatory blood pressure measurement.
Read More
How New Antimicrobial Options Could Change Existing Care, Affect Stewardship Programs
January 10th 2015J. Russell May, PharmD, FASHP, clinical professor at Georgia Regents University College of Pharmacy, discusses how new antimicrobial options could change existing care and affect stewardship programs.
Watch
Pharmacy Today Launches Daily Edition Newsletter
January 9th 2015This week, the American Pharmacists Association's Pharmacy Today launched a new daily newsletter to meet the increasing need for news, facts and information supplied when it happens. Delivered each business morning, the daily edition of Today provides custom-crafted summaries of the day's top news stories written by Today's newsletter partner, Information Inc., and Pharmacy Today reporters.
Read More
Actavis Resubmits Cariprazine Approval Application to FDA
January 8th 2015The FDA has acknowledged receipt of Actavis's resubmitted New Drug Application for its investigational atypical antipsychotic, cariprazine, which is indicated for the treatment of patients with schizophrenia and manic or mixed episodes associated with bipolar I disorder.
Read More